Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux

Nonalcoholic fatty liver disease (NAFLD) is a kind of liver lipid synthesis and degradation imbalance related with metabolic syndrome. Celecoxib shows the function of ameliorating NAFLD, but the underlying mechanisms remain unknown. Here, we discuss the possible mechanisms of celecoxib alleviating N...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Liu, Cong, Liu, Lian, Zhu, Hai-Dan, Sheng, Jia-Qi, Wu, Xiao-Li, He, Xing-Xing, Tian, De-An, Liao, Jia-Zhi, Li, Pei-Yuan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841322/
https://ncbi.nlm.nih.gov/pubmed/29515134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-22339-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia